{"name":"Pharmasyntez","slug":"pharmasyntez","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Seroguard","genericName":"Seroguard","slug":"seroguard","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"Seroguard","genericName":"Seroguard","slug":"seroguard","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxPSU9zOHg1Y1hzTXVoLW8zNndqQUIxd2FVMFhyOVBtMGhjaF92aXVHX2lGYVl5bkMwT21PMTJvZk9LMmU2ckx2Y0JRd3dOcHVTYU1jcC0zZW81bjdmazBBNkdZZXhxbW9DS2h6MGNFeHY4a0lxa3AwSFBHckZwN0VOcmlKbGtNenU0T0ROQUFVZVVoVlU1UGtHc1BmaGJtcUsyS0czdC15ejFfLTRWNEpkbHJRNzZyQWl3UUdYOEUxd1cwWGM?oc=5","date":"2025-10-22","type":"pipeline","source":"The Pharma Letter","summary":"Russia’s Pharmasyntez to begin joint production of drugs with China’s Hualan Bio - The Pharma Letter","headline":"Russia’s Pharmasyntez to begin joint production of drugs with China’s Hualan Bio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilgFBVV95cUxQRVBHbld4Q2swV2E2WHlGalRyNTEtZTNHaGNBS2xxeVBoNnRDeVpvbWFiMlhPaTN3YXpUODNHbXFhS0pLdDE1R2FqTGJna0ZfS2VHek0wYVFOMk5FZGRTeUJIdUE1MW9GZldVal9VMDBtVU1ndGZ0SnVWSGQzYklNNFgtWUVWeFYzZDlqaE93WmVmT3hlLUHSAZYBQVVfeXFMUEVQR25XeENrMFdhNlh5RmpUcjUxLWUzR2hjQUtscXlQaDZ0Q3lab21hYjJYT2kzd2F6VDgzR21xYUtKS3QxNUdhakxiZ2tGX0tlR3pNMGFRTjJORWRkU3lCSHVBNTFvRmZXVWpfVTAwbVVNZ3RmdEp1VkhkM2JJTTRYLVlFVnhWM2Q5amhPd1plZk94ZS1B?oc=5","date":"2025-10-09","type":"pipeline","source":"Новости GxP","summary":"Pharmasyntez and China’s Hualan Bio have agreed to cooperate - Новости GxP","headline":"Pharmasyntez and China’s Hualan Bio have agreed to cooperate - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxPek9FejN5TG1LZmoyOHVVTGNyTm5qWmttLXVJWkZaaVlPQUpIU3h2eXl0OEtnbFJ3WUVta3I3UE0ybVhwdEJ5VzRYdXFINFJLMmVOWk9FNlNIbFA0WnRScXpLT1hDRTFmN0xvNWlBalBLX0J2VjhSVElJQ28yZG1UUXdoaThIcEZVSDN5VHkyR3lYMlYxdS1kU0tSVGdSZ1UzUWFr?oc=5","date":"2025-05-21","type":"pipeline","source":"The Pharma Letter","summary":"Pharmasyntez plans massive expansion of portfolio of innovative drugs - The Pharma Letter","headline":"Pharmasyntez plans massive expansion of portfolio of innovative drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxQWWxpaEpDeWpWTzRVWHBDZUxZMG1haEdXN2tyajVjcU9rSFhJRG5kS04ydjBSUWs3Z01ob3BUUllVNlJUX2RJUWVIc2VUMFZ6SkZlVXBVcUNIUEo5VG00QUFEaGc2c2FGczdFR2RFbDRxOUZfZkJZem0xVHNWbnJFdDdHZGVmVlczSm9MOW1DWVJRTGJWakwtcTRhUUTSAZwBQVVfeXFMUFlsaWhKQ3lqVk80VVhwQ2VMWTBtYWhHVzdrcmo1Y3FPa0hYSURuZEtOMnYwUlFrN2dNaG9wVFJZVTZSVF9kSVFlSHNlVDBWekpGZVVwVXFDSFBKOVRtNEFBRGhnNnNhRnM3RUdkRWw0cTlGX2ZCWXptMVRzVm5yRXQ3R2RlZlZXM0pvTDltQ1lSUUxiVmpMLXE0YVFE?oc=5","date":"2025-05-13","type":"pipeline","source":"Новости GxP","summary":"Pharmasyntez has announced the release of three innovative drugs - Новости GxP","headline":"Pharmasyntez has announced the release of three innovative drugs - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxOZUVIUmxXbi04OTR6dXZmZERnSjM0ZEVKTmc2cmsycTF6NFFkU0JMNEF2ejQ2Z3RuYXNZd0Q5OFhnZDdXVWlhc2txdGUtZGpoX1RieEJVblN2YWNPQ01uWS16T0IxQjQ3dVU4d241emRTOGEyQkwwSGh0SGVFWVBoNzhlOHE4Y2RWQ2VseDhEc3ZHRHN00gGUAUFVX3lxTE5lRUhSbFduLTg5NHp1dmZkRGdKMzRkRUpOZzZyazJxMXo0UWRTQkw0QXZ6NDZndG5hc1l3RDk4WGdkN1dVaWFza3F0ZS1kamhfVGJ4QlVuU3ZhY09DTW5ZLXpPQjFCNDd1VTh3bjV6ZFM4YTJCTDBIaHRIZUVZUGg3OGU4cThjZFZDZWx4OERzdkdEc3Q?oc=5","date":"2025-04-28","type":"pipeline","source":"Новости GxP","summary":"Pharmasyntez has developed a new drug against blood cancer - Новости GxP","headline":"Pharmasyntez has developed a new drug against blood cancer - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwFBVV95cUxOSUg3N1kwTm1YYmZKdTJGN2lkMDlhcXQwRF9SSDA3c2hod3lYMkNaaHBkazBVTEtSRU1xck8zRERoY2dJeHBZc0xTNXBDSU44RHZZWDBkUUNmbTNJQUVhWVA5UWV5cHprQW10SkxGMTl3MTdla0JLeWo5UUZuUk1PRXpORnJ3bEhPdEtv0gGLAUFVX3lxTE5JSDc3WTBObVhiZkp1MkY3aWQwOWFxdDBEX1JIMDdzaGh3eVgyQ1pocGRrMFVMS1JFTXFyTzNERGhjZ0l4cFlzTFM1cENJTjhEdllYMGRRQ2ZtM0lBRWFZUDlRZXlwemtBbXRKTEYxOXcxN2VrQkt5ajlRRm5STU9Fek5GcndsSE90S28?oc=5","date":"2025-03-20","type":"pipeline","source":"Новости GxP","summary":"Pharmasyntez Group to enter the African drug market - Новости GxP","headline":"Pharmasyntez Group to enter the African drug market - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2024-11-02","type":"pipeline","source":"India.Com","summary":"Meet Jaipur-born businessman, a billionaire, owns pharma company in Russia, played key role in making Sputnik - India.Com","headline":"Meet Jaipur-born businessman, a billionaire, owns pharma company in Russia, played key role in making Sputnik","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxOUTJsSU44dHhOYUhKZkRPRE9Nakg2NjZQOXRiZmRBNGhMbVlPbHJYRW1GSkE2ckZadFNVYjRJU3VfSFVDaTdaOEFoWkQxN0d6SjRmQnZfRzdLSzNLckU3OXVQM0FIWm1PYl92T1FSQ0JiQ0FoelA5UjdsanhyNTZkZF9nYU1kckUySHUxQzRrQmRVcng1eEowdzFla0FrMU9y0gGgAUFVX3lxTE5RMmxJTjh0eE5hSEpmRE9ET01qSDY2NlA5dGJmZEE0aExtWU9sclhFbUZKQTZyRlp0U1ViNElTdV9IVUNpN1o4QWhaRDE3R3pKNGZCdl9HN0tLM0tyRTc5dVAzQUhabU9iX3ZPUVJDQmJDQWh6UDlSN2xqeHI1NmRkX2dhTWRyRTJIdTFDNGtCZFVyeDV4SjB3MWVrQWsxT3I?oc=5","date":"2023-12-14","type":"regulatory","source":"Новости GxP","summary":"Health Ministry approved Pharmasyntez’s schizophrenia treatment drug - Новости GxP","headline":"Health Ministry approved Pharmasyntez’s schizophrenia treatment drug - Новости GxP","sentiment":"positive"},{"url":"https://news.google.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?oc=5","date":"2023-09-08","type":"pipeline","source":"Новости GxP","summary":"Pharmasyntez has made it’s first delivery of anticancer drugs to the Dominican Republic - Новости GxP","headline":"Pharmasyntez has made it’s first delivery of anticancer drugs to the Dominican Republic - Новости GxP","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxORUJFRW9Kd2VxcTFvTzNFRWNpMWJQeUctaF9uMS0tQmNWR3dLUVdaQlpDS1VfMmNfSHFNWlZ0bkU2NHp5Ync5Y2xYVzFraHBudThUa1cxUzVYUmVOX21aZlI2NThScEdzVmJYT2dkZ0ZhVkRzSzFfSm5iUUNBZFJCY25ReW5waFRHWEpBb3VfeFpXWUlSUzJFSXpPMkhNY2tGbHE0c3BBUlp6T29ZVjl5VjF0UlRUU0JIMnpMbzM2R1FKdGprX3c?oc=5","date":"2021-02-05","type":"deal","source":"Generics and Biosimilars Initiative","summary":"Partnerships formed and extended between Isu Abxis/Pharmasyntez and Alvotech/Fuji Pharma - Generics and Biosimilars Initiative","headline":"Partnerships formed and extended between Isu Abxis/Pharmasyntez and Alvotech/Fuji Pharma","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}